C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings

Patents for C07D 233 - Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings (34,408)
11/2009
11/18/2009	EP2119440A1 Amidino derivatives for use in the prevention or treatment of retinitis pigmentosa and Leber's disease
11/18/2009	EP2118143A1 Reformation of ionic liquids
11/18/2009	EP2118071A2 Alkyl h-phosphonates of n,n'-dialkylimidazoliums and of quaternary ammoniums, and uses thereof
11/18/2009	EP2118070A1 Production of ionic liquids
11/18/2009	EP2117540A1 New use of glutaminyl cyclase inhibitors
11/18/2009	EP2117310A2 Chemical compounds
11/18/2009	EP1963278B1 Substituted imidazoline derivatives
11/18/2009	EP1370525B1 Biguanide derivatives
11/18/2009	EP0839139B2 Hydrophobic ionic liquids
11/18/2009	EP0760811B1 Imidazole derivatives as histamine receptor h3 modulators
11/18/2009	CN101583603A Aromatic 1,4-di-carboxylamides and their use
11/18/2009	CN100561619C Aluminum electrolytic capacitor, preparing method for quaternary ammonium salt for super capacitor
11/18/2009	CN100560572C Alkaline amino acid salt of Glycididazole acid, preparation and application
11/18/2009	CN100560571C Preparation process of 2-nitro imido imidazolyl alkane
11/18/2009	CN100560548C Synthesis process of 18F labeled positive electron radioactive tracer with ionic liquid as phase transfer catalyst
11/18/2009	CN100560070C Imidazol derivatives having affinity for alpha 2 receptors activity
11/17/2009	CA2339090C Methimazole derivatives and tautomeric cyclic thiones to treat autoimmune diseases
11/12/2009	WO2009137651A2 Fungicidal substituted azoles
11/12/2009	WO2009137538A2 Fungicidal substituted azoles
11/12/2009	WO2009137343A1 Therapeutic substituted hydantoins, and related compounds
11/12/2009	WO2009136609A1 Ionic liquid
11/12/2009	WO2009136073A1 Preparation of alkylimidazolidone (meth)acrylates in water
11/12/2009	WO2009135600A1 Catalysts for the synthesis of polyurethanes
11/12/2009	US20090281329 Removing hydrocarbon impurities from acetic acid by ionic liquid extraction
11/12/2009	US20090281319 Preparation of platinum (ii) complexes
11/12/2009	US20090281310 Cinnamide compound
11/12/2009	US20090281101 5-(3-(3-(4-hexanoylphenyl)-2,5-dioxoimidazolidin-4-yl)propyl)thiophene-2-carboxylic acid; prostaglandin agonist; ocular hypotensive agent; post-sergical and post-laser trabeculectomy ocular hypertensive episodes, glaucoma, and as presurgical adjuncts
11/12/2009	DE102008026341A1 Katalysatoren zur Synthese von Polyurethanen Catalysts for the synthesis of polyurethanes
11/12/2009	CA2723894A1 Therapeutic substituted hydantoins, and related compounds
11/11/2009	EP2116534A1 Process for production of binuclear metal complex
11/11/2009	EP2116242A1 New pharmaceutical composition
11/11/2009	EP2114969A2 High stability polyionic liquid salts
11/11/2009	EP2114899A2 Controlled release of active aldehydes and ketones from equilibrated dynamic mixtures
11/11/2009	EP2114895A1 Talarazole metabolites
11/11/2009	EP2019874B1 Porous metal organic framework based on pyrroles and pyridinones
11/11/2009	EP1874745B1 New 3-phenylpropionic acid derivatives and their use as ppar- gamma receptor ligands
11/11/2009	EP1255726B1 (r)-2-aryl-propionamides, useful in the inhibition of il-8 induced chemiotaxis of neutrophils
11/11/2009	CN101578272A 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
11/11/2009	CN101578271A 4-imidazolines as TAAR's ligands
11/11/2009	CN100558711C Polymerization method using positive imidazol ion initiator and positive imidazol ion initiator compound and its synthesizing method
11/11/2009	CN100558697C Cycloalkyl inhibitors of potassium channel function
11/11/2009	CN100558409C Thiotungstate analogues and uses thereof
11/11/2009	CN100558356C Method of using benzenesulphoamides that are cyclooxygenase-2-inhibitors in the treatment and prevention of neoplasia
11/10/2009	US7615644 Use of ionic liquids as coordination ligands for organometallic catalysts
11/10/2009	US7615208 Administering a radionuclide-labeled bis-aminoethanethiol (BAT) tetradentate targeting ligand conjugate, which is a folate receptor targeting ligand, an agent that mimics glucose, annexin V, colchicine, glutamate pentapeptide, or a tumor hypoxia targeting ligand
11/10/2009	US7615137 Process for recovering caprolactam from aqueous caprolactam product using in situ prepared alkali amino caproate
11/10/2009	CA2315262C Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
11/05/2009	WO2009134741A1 Dual-acting antihypertensive agents
11/05/2009	WO2009133923A1 Agricultural/horticultural bactericidal agent comprising 1,2,3-substituted imidazolium salt as active ingredient
11/05/2009	US20090275727 Peptide turn mimetics
11/05/2009	US20090275714 New Ruthenium Complexes as Catalysts for Metathesis Reactions
11/05/2009	US20090275617 such as 3-[(1S,3R)-3-fluorocyclopentylamino]methyl-5-(5-fluoro-6-methylpyridin-3-yl)-1-isopropyl-4-methyl-1H-pyrazole, having opioid receptor antagonistic activity, used analgesics or for the treatment of diabetes, neurodegenerative diseases, drug abuse, hypotension, schizophrenia , dementia or obesity
11/05/2009	US20090275603 NF- kB Inhibitors And Uses Thereof
11/05/2009	US20090274753 Ph-sensitive polymeric micelles for drug delivery
11/05/2009	US20090274632 Identification of human T2R receptors that respond to bitter compounds that elicit the bitter taste in compositions, and the use thereof in assays to identify compounds that inhibit (block) bitter taste in composition and use thereof
11/04/2009	EP1727804B1 N1 - ((pyrazol-1-ymethyl) -2-methylphenyl)- phatalamide derivatives and related compounds insecticides
11/04/2009	EP1432700B1 Spiro-hydantoin compounds useful as anti-inflammatory agents
11/04/2009	EP1339684B1 Mch antagonists and their use in the treatment of obesity
11/04/2009	EP1311488B1 Substituted imidazoles as tafia inhibitors
11/04/2009	CN101570517A 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
11/03/2009	US7612212 Substituted hydantoins
11/03/2009	US7612064 Sulfopyrroles
11/03/2009	CA2443724C Novel, arylsusfonamide compounds for the treatment of obesity, type ii diabetes and cns-disorders
10/2009
10/29/2009	WO2009132087A1 Thiophene derivatives useful as ocular hypotensive agents
10/29/2009	WO2009131096A1 Compound having npy y5 receptor antagonist activity
10/29/2009	WO2009130873A1 Hydroalkane sulfonate and use thereof
10/29/2009	WO2009130735A1 Fatty acid derivatives for oral administration endowed with high palatability
10/29/2009	WO2009106640A3 N-benzyl imidazole derivatives and their use as aldosterone synthase inhibitors
10/29/2009	US20090270634 hydrolyzing the brominated product of 1-methylhydantoin to form 5-hydroxy-1-methylimidazolidin-2,4-dione, drug such as for renal failure; purified product for renal patients
10/29/2009	US20090270475 Inhibition of bacterial biofilms with imidazole-phenyl derivatives
10/29/2009	US20090270473 Dual-acting antihypertensive agents
10/29/2009	US20090270367 Substituted hydroxyethylamine aspartyl protease inhibitors
10/29/2009	US20090270248 Basic ionic liquids
10/29/2009	US20090269673 Process for the preparation of compounds containing perfluoroalkanesulfonic acid groups
10/29/2009	CA2722312A1 Thiophene derivatives useful as ocular hypotensive agents
10/29/2009	CA2722159A1 Substituted phenylimidazole compounds and their use as ido inhibitors
10/29/2009	CA2721756A1 Fatty acid derivatives for oral administration endowed with high palatability
10/29/2009	CA2721576A1 Compound having npy y5 receptor antagonist activity
10/29/2009	CA2720818A1 Substituted phenoxybenzamides
10/28/2009	EP2111394A1 Compounds with a combination of cannabinoid-cb1 antagonism and serotonin reuptake inhibition
10/28/2009	CN101565608A Preparation method of novel acidified corrosion inhibitor and use thereof
10/28/2009	CN100554257C 1-(4-benzyl-piperazin-1-yl)-3-phenyl-propenone derivatives
10/27/2009	US7608725 Making 2-nitroimidazoles involving the selective nitration of N-substituted imidazoles which does not use a non-acidic alkyl nitrate; using potassium nitrate and trifluotoacetic anhydride to generate trifluoroacetyl nitrate in situ; cost efficiency; environmetally friendly; efficiency; antihypoxic
10/27/2009	US7608724 Antibacterial and/or antiprotozoal nitromidazole derivative compounds with urease inhibitor activity, process for preparing these compounds and use in pharmaceutical compositions and medicines
10/27/2009	US7608633 1-(4-Octylphenoxy)-3-(pyrrol-1-yl)propan-2-one, for example; for preventing and treating diseases caused by an increased activity of this enzyme, such as inflammation, pain, fever, allergies, asthma, psoriasis and endotoxic shock
10/27/2009	US7608248 phenylalanine and tyrosin having a labeled pattern ( deuteration) which allows the chain-assignment of the signals originated from the main chain to extend even to the assignment of the ring portions; when determining protein structure by nuclear magnetic resonance, permits improvment in the sensitivity
10/27/2009	CA2376355C N-heterocyclic derivatives as nos inhibitors
10/27/2009	CA2318145C Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
10/22/2009	WO2009128479A1 Imidazoline derivative
10/22/2009	WO2009127615A1 Novel imidazole derivatives having microbiocidal activity
10/22/2009	WO2009127338A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/22/2009	US20090264424 Vanilloid receptor ligands and their use in treatments
10/21/2009	EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009	EP1853582B1 Heterocyclylamide-substituted imidazoles
10/21/2009	CN101563326A Clathrate compound, curing catalyst, composition for forming cured resin, and cured resin
10/21/2009	CN101560201A Technique for extracting high purity puerarin and diverse rare medical components from root of kudzuvine
10/21/2009	CN101560189A Metronidazole and compound for substituting salicylic acid and preparation method and application thereof
10/21/2009	CN101560188A Method for separating and purifying 2-methylimidazole crystal impurity
10/21/2009	CN101560187A Binary eutectic ionic liquid and preparation method thereof
10/21/2009	CN101559053A 5-membered heterocycle derivatives, production thereof and use thereof as medicaments

1 ... 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 ... 345